1. Center for Molecular Biosciences Innsbruck (CMBI), Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria
2. Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
3. Department of Immunology, University of Oslo, Oslo, Norway
4. Department of Immunology, University of Oslo, Oslo University Hospital Rikshospitalet, Oslo, Norway
5. Institute of Clinical Medicine and Department of Pharmacology, University of Oslo, Oslo, Norway
6. Authera AS, Oslo Science Park, Oslo, Norway
7. National Biologics Facility, Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
8. Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
9. Roche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany
10. Department of Chemical Engineering, Pharmaceutical Sciences and Biomedical Engineering, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, USA
11. Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK
12. Maxion Therapeutics, Babraham Research Campus, Cambridge, UK